Kyverna Therapeutics (KYTX) Net Cash Flow (2023 - 2026)
Kyverna Therapeutics (KYTX) recorded Net Cash Flow of -$385,000 in Q2 2026, compared with -$3.47 million a year earlier.
Powered by 
Analysis
Kyverna Therapeutics (KYTX) Net Cash Flow (2023 - 2026) Analysis & Trends
On a TTM basis, Kyverna Therapeutics' Net Cash Flow came in at -$21.6 million as of Jun 30, 2026; for FY2025, it was $27.47 million, down 55.6% from FY2024.
- Across earlier years, Net Cash Flow came in at $61.91 million in FY2024 and -$3.08 million in FY2023.
- Quarterly Net Cash Flow has ranged from -$92.67 million in Q2 2024 to $189.65 million in Q1 2024 over the past five years.
- Per Business Quant, the preceding three quarters came in at -$91.9 million (Q1 2026), $89.93 million (Q4 2025) and -$19.24 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.53 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 757.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.62 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.95 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -4.43 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -722.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 652.90 Mn |
| 10 | Kyverna Therapeutics | 418.68 Mn | 418.68 Mn | - | -385,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -385,000.00 |
| Mar 31, 2026 | -91.90 Mn |
| Dec 31, 2025 | 89.93 Mn |
| Sep 30, 2025 | -19.24 Mn |
| Jun 30, 2025 | -3.47 Mn |
| Mar 31, 2025 | -39.75 Mn |
| Dec 31, 2024 | -8.10 Mn |
| Sep 30, 2024 | -26.97 Mn |
| Jun 30, 2024 | -92.67 Mn |
| Mar 31, 2024 | 189.65 Mn |
| Dec 31, 2023 | 11.68 Mn |
| Sep 30, 2023 | -30.46 Mn |
| Jun 30, 2023 | 13.65 Mn |
| Mar 31, 2023 | 2.05 Mn |
API Access
Kyverna Therapeutics Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=KYTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "KYTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=KYTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();